FGF9 treatment reduces off-target chondrocytes from iPSC-derived kidney organoids
Virginie Joris, Anika Schumacher, Maria Paula Marks, Maria José Eischen-Loges, Sofia Fallo, Martijn van Griensven, Vanessa L.S. LaPointe
This paper shows that extending FGF9 treatment in iPSC-derived kidney organoids reduces off-target cartilage without affecting renal structures.
npj Regenerative Medicine · Aug 30, 2025Peer-reviewedCell Biology